Equities

Amplia Therapeutics Ltd

Amplia Therapeutics Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.063
  • Today's Change0.003 / 5.00%
  • Shares traded273.02k
  • 1 Year change-28.77%
  • Beta1.1520
Data delayed at least 20 minutes, as of May 23 2024 06:56 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • ATX:ASX price moved over +1.72% to 0.059
  • ATX:ASX trading volume exceeds daily average by +18.07%
  • ATX:ASX price falls below 15-day moving average to 0.059 at 12:04 BST
  • ATX:ASX price rises above 15-day moving average to 0.062 at 11:25 BST

Key statistics

On Thursday, Amplia Therapeutics Ltd (ATX:ASX) closed at 0.063, 14.55% above the 52 week low of 0.055 set on May 21, 2024.
52-week range
Today
0.055May 21 20240.0914Aug 11 2023
Open0.06
High0.064
Low0.059
Bid0.059
Offer0.067
Previous close0.06
Average volume400.23k
Shares outstanding271.61m
Free float225.33m
P/E (TTM)--
Market cap16.30m AUD
EPS (TTM)-0.0224
AUD
Data delayed at least 20 minutes, as of May 23 2024 06:56 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.